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Role of ROS and HMGB1 in Contact Allergen–
Induced IL-18 Production in Human Keratinocytes
Valentina Galbiati1, Angela Papale1, Corrado L. Galli1, Marina Marinovich1 and Emanuela Corsini1
Keratinocytes have a key role in all phases of allergic contact dermatitis. We have recently identified the
possibility to use IL-18 production for the in vitro identification of contact allergens. The purpose of this study
was to characterize the molecular mechanisms underlying allergen-induced IL-18 production, in order to identify
the cellular source of reactive oxygen species (ROS) and the danger signals involved. The NCTC2544 cell line was
exposed to three contact allergens, namely p-phenylenediamine (PPD), 2,4-dinitrochlorobenzene (DNCB), and
citral, in the presence or absence of diphenylene iodonium (DPI), allopurinol, and rotenone to identify the
source of ROS, and to anti-Toll-like receptor 4 antibody and glycirrizic acid to characterize the danger-associated
molecular pattern molecules. In the case of PPD, the induction of IL-18 can be modulated by rotenone,
allopurinol, and DPI. In the case of DNCB, rotenone completely prevents the induction of IL-18, whereas for
citral, DPI completely prevents the induction of IL-18. We demonstrated the ability of all allergens tested to
induce the release of high-mobility group protein B1 (HMGB1). Its sequester by glycirrizic acid significantly
modulates PPD-induced IL-18 production and completely prevents DNCB- and citral-induced IL-18. We found
that different intracellular sources of ROS are triggered by contact allergens, and an important role for HMGB1 in
chemical allergen-induced IL-18 production was demonstrated.
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INTRODUCTION
Allergic contact dermatitis is an important occupational and
environmental disease caused by topical exposure to low-
molecular-weight chemical allergens (Thyssen et al., 2007;
Peiser et al., 2012). It represents a delayed-type hypersen-
sitivity reaction caused mainly by reactive T-helper 1 and
(IFN)-g-producing CD8þ T cells (Tc1), which requires pre-
vious sensitization by the same chemicals (Nosbaum et al.,
2005; Cavani et al., 2007; Basketter et al., 2008). The
development of allergic contact dermatitis requires the
activation of innate immune cells, such as keratinocytes
(KCs), dendritic cells, and T cells.
It is the skin microenvironment that provides the danger-
associated molecular patterns or danger-associated molecular
pattern molecules (DAMPs), including reactive oxygen species
(ROS), uric acid, hyaluronic acid fragments, high-mobility group
protein B1 (HMGB1), and adenosine triphosphate, that are
required for the activation of pattern recognition receptors (PRRs)
and full activation of dendritic cells. KCs have a key role in skin
sensitization, as they provide the essential danger signals, they
are involved in the protein haptenation process, and supply
enzymes that are necessary for the metabolic activation of
prohaptens (Hennen et al., 2011; Kim and Choi, 2010).
Human KCs constitutively express several cytokines, includ-
ing pro-IL-1a, pro-IL-1b, and pro-IL-18. The IL-1 family is a
group of cytokines involved in local and systemic inflamma-
tory reactions. Acute-phase proteins, cytokines, and adhesion
molecules are induced by IL-1. IL-18, originally identified as
an IFN-g, has an important role in Th-1-type immune response
enhancing the secretion of proinflammatory mediators such as
TNF-a, IL-8, and IFN-g and also in the induction of allergic
contact sensitization (Shornick et al., 1996; Wang et al.,
1999). IL-1b and IL-18 are synthesized as preforms, which
require proteolytic maturation by cysteine protease caspase-1,
which must first be activated by the inflammasome (He et al.,
2012; Lu et al., 2012). The inflammasome is a complex
consisting of a receptor linked to inactive procaspase-1 by an
intermediate apoptosis-associated speck-like protein contain-
ing a caspase activation and recruitment domain (Menzel
et al., 2011; Menu and Vince, 2011; Tschopp and Schroder,
2010). IL-1 and the inflammasome are involved in sensing
contact sensitizers and triggering an innate immune response
to these, which subsequently has a role in triggering the
adaptive immune response to contact sensitizers in the skin
(Sutterwala et al., 2006; Watanabe et al., 2007). A wide range
of proinflammatory stimuli, including pathogen-associated
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molecular patterns and endogenous damage-associated
molecular patterns (Contassot et al., 2012), activate the NLRP3
inflammasome. Among other DAMPs, the evolutionarily
conserved nonhistone chromatin-binding protein HMGB1
is released into the extracellular space during infection or
injury by activated immune cells and damaged cells. HMGB1
functions as a proinflammatory mediator, it is a Toll-like
receptor 4 (TLR4)-agonist, and it contributes importantly to the
pathogenesis of inflammatory diseases (Lu et al., 2013).
As all NLRP3 activators induced the generation of ROS, it
has been reported that ROS production triggers NLRP
inflammasome activation (Tshopp and Schroder, 2010).
Generation of ROS induces the dissociation of thioredoxin
from thioredoxin-interacting protein. Then the latter is able to
bind NLRP3, which induces inflammasome activation (Zhou
et al., 2010). The imbalance between the formation of ROS and
the ability to detoxify these oxidizing radicals can produce a
cellular state known as oxidative stress (Valko et al., 2007).
Recent evidence provided from our group has shown that
IL-18 production in human KCs can be used as a sensitive
method to identify contact allergens, discriminating them
from respiratory allergens and irritants (Corsini et al., 2009;
Galbiati et al., 2011; Corsini et al., 2013). As a mechanism
of action, we could demonstrate a role for oxidative stress,
NF-kB, and p38 mitogen-activated protein kinase (MAPK)
activation in p-phenylenediamine (PPD)-induced IL-18
production. The aim of the present paper was to identify the
intracellular source of ROS and the possible DAMPs involved
in the activation of the inflammasome, leading to IL-18
activation and production.
RESULTS
Role of rotenone and allopurinol in allergen-induced IL-18
production
As reference allergens, PPD, 2,4-dinitrochlorobenzene
(DNCB), and citral were used. The concentrations used were
selected from previously published data (Corsini et al., 2009;
Galbiati et al., 2011; Corsini et al., 2013).
To investigate the intracellular source of ROS, specific
inhibitors of the three main cellular sources of ROS, namely
rotenone (mitochondrial electron transport), diphenylene
iodonium (nicotinamide adenine dinucleotide phosphate oxi-
dase and nitric oxide synthetase), and allopurinol (xanthine
oxidase), were used. The list of inhibitors used, the concentra-
tions used, cytotoxicity, and the effect on IL-18 are reported in
Table 1. At the concentrations used, none of the inhibitors
were cytotoxic or affected IL-18 content.
As shown in Figure 1, all sources appear to be involved
to some degree in allergen-induced IL-18, as all inhibitors
were able to significantly modulate allergen-induced
IL-18. However, we found that the different allergens
tested seem to preferentially trigger ROS production from
the different intracellular sources. In particular, a central role
of mitochondria could be demonstrated for DNCB and of
nicotinamide adenine dinucleotide phosphate oxidase for
citral, whereas for PPD a main source of ROS could not be
identified as all inhibitors equally modulated the induction
of IL-18.
The effects of different sources of ROS
To investigate the direct effect of an exogenous font of ROS on
cytokines production, H2O2 was used. Dose-response experi-
ments were performed starting from H2O2 1mM as the highest
concentration. PPD (30mg ml1) was used as a positive
control. We determined IL-18, IL-1a, and IL-8 production.
Cell viability was evaluated in parallel with the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay.
As shown in Figure 2, for IL-18 (panel a) and IL-1a (panel b)
only at the two highest concentrations of H2O2 (1mM and
0.5mM) a statistical significant increase in cytokine production
was observed. These concentrations were associated with high
cytotoxicity (about 50% of mortality). Otherwise, H2O2 was
able only to induce a statistically significant IL-8 release at a
concentration of 0.1mM (panel c).
The results obtained suggest that KCs react differently to
exogenous or to endogenous oxidative stresses. In particular,
we found that an external font of ROS, such as H2O2, was
able to induce IL-18 and IL-1a production only at cytotoxic
concentrations, whereas contact allergens induced a dose-
related IL-18 production at noncytotoxic concentrations (via-
bility 480%).
To estimate the expression of ROS (H2O2), we used the
dichlorofluorescein diacetate assay. As shown in Figure 2,
panel d, and in agreement with literature data, to a different
extent all allergens tested induce an oxidative stress in KCs.
Role of caspase-1 and TLR4 in allergen-induced IL-18 production.
Z-VAD-FMK, a cell-permeant pan caspase inhibitor that irrever-
sibly binds to the catalytic site of caspases, and a neutralizing
anti-TLR4 antibody were used to investigate the role of the
inflammasome and TLR4 in allergen-induced IL-18 production.
DNCB- and citral-induced IL-18 were completely prevented by
Z-VAD-FMK (Figure 3a) and by anti-TLR4 antibody (Figure 3b),
whereas PPD-induced IL-18 was significantly reduced but com-
pletely not abrogated, possibly indicating the involvement of
other pathways.
Table 1. Inhibitors tested in the NCTC2544 assay, their
cytotoxicity, and effect on IL-18
Chemicals Concentrations
Cell
viability1
Intracellular
IL-182
Allopurinol 10mM 109±10 0.98±0.01
Anti-TLR4
antibody
2mg ml1 97±2 1.10±0.08
DPI 5mM 99±2 1.04±0.13
Glycirrizic acid 100mM 98±5 0.82±0.06
Rotenone 20mM 101±2 0.94±0.05
Z-VAD-FMK 10mM 100±1 1.05±0.07
Abbreviations: DPI, diphenylene iodonium; TLR4; Toll-like receptor 4.
Cells were treated for 24 hours with the selected inhibitors. Cell viability
was assessed by the MTT reduction assay and intracellular IL-18 by ELISA.
Each value represents the mean±SD, n¼ 4.
1Expressed as % of viable cells versus vehicle-treated cells (100%).
2Expressed as SI (stimulation index).
V Galbiati et al.
Role of ROS and HMGB1
2720 Journal of Investigative Dermatology (2014), Volume 134
DAMPs. We focused our attention on HMGB1 as possible
DAMP associated with allergen-induced IL-18. By measuring
the release of HMGB1 (Figure 4a) and using its direct inhibitor
glycirrizic acid (Figure 4c), we could demonstrate that all
allergens tested induced HMGB1 release and its sequestration
by glycirizzic acid prevented IL-18 induction, demonstrating the
role of HMGB1 in allergen-induced IL-18. In addition, the release
of HMGB1 can be significantly reduced by Z-VAD-FMK
(Figure 4b). This is consistent with published data, which showed
that the secretion of HMGB1 requires inflammasome and caspase
activation, probably associated with the translocation of HMGB1
from the nucleus to the cytoplasm (Apetoh et al., 2007; Yamada
et al., 2011; Lu et al., 2012).Data presented show the involvement
of this DAMP in allergen-induced KC activation. This is not
limited to the NCTC2544 cell line, as we also observed the
release of HMGB1 in human reconstituted epidermis treated with
increasing concentrations of PPD, DNCB, and citral (Figure 4d),
demonstrating the release of this protein not only in the KC cell
line but also in a more complex in vitro system.Finally, to
investigate the role of HMGB1 in allergen-induced IL-8 and
IL-1a production, cells were pretreated with glycirrizic acid and
then with PPD. As shown in Table 2, glycirizzic acid was able to
prevent the intracellular IL-1a production induced by PPD,
without affecting IL-8 production.
DISCUSSION
We found that contact allergens, acting as danger signals,
stress the cells inducing oxidative stress and DAMP release,
and stimulate the assembly of the inflammasome, resulting in
IL-18 neosynthesis and release. Different intracellular sources
of ROS, including mitochondria, nicotinamide adenine dinu-
cleotide phosphate oxidase, and xanthine oxidase, seem to be
involved, as allergen-induced IL-18 can be modulated to a
different extent by different selective inhibitors.
Danger signals are typically divided into pathogen-asso-
ciated molecular patterns and DAMPs. The majority of contact
allergens have the ability to deliver both antigenic and danger
signals (McFadden et al. 2013). In this case, the danger signals
are related to the irritant capacity of the chemical allergens,
resulting in cell and tissue trauma and the elaboration of
DAMPs, which are the key events for successful contact
hypersensitivity. Among the possible DAMPs, here, we
demonstrated the ability of contact allergens to induce the
release of HMGB1, which via TLR4 induces IL-18 neosyn-
thesis in KCs. HMGB1 is a major mediator of endotoxin shock
(Wang et al., 2002), and it acts on several immune cells to
trigger inflammatory responses as DAMPs (Scaffidi et al.,
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Figure 1. Role of mitochondria, nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase, and xanthine oxidase in allergen-induced IL-18
production. NCTC2544 cells were treated with rotenone (20mM), allopurinol
(10mM), and diphenylene iodonium (DPI) (5mM) for 1 hour and then with
p-phenylenediamine (PPD) (30mg ml 1), 2,4-dinitrochlorobenzene (DNCB)
(2mg ml1), citral (20mg ml 1), or DMSO (0.2% final concentration) as vehicle
control for 24 hours. Results are expressed as mean±SD, n¼ 4. Statistical
analysis was performed with analysis of variance followed by Bonferroni post-
tests, with **Po0.01 versus vehicle-treated cells; ##Po0.01 versus cells treated
with inhibitors alone.
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2002). HMGB1 can induce dendritic cell maturation via
upregulation of CD80, CD83, CD86, and CD11c; it can
induce production of proinflammatory cytokines in myeloid
cells (i.e., IL-1, TNF alpha, IL-6 ,and IL-8), as well as
upregulate the expression of cell adhesion molecules (i.e.,
ICAM-1, VCAM-1) on endothelial cells (Ferrari et al., 1996;
Gardella et al., 2002; Scheibner et al. 2006). Extracellular
HMGB1 can bind to TLR2/4 and RAGE on effector cells in
order to induce inflammation, chemotaxis, and repair
responses (Vande Walle et al., 2011). We could demonstrate
the ability of contact allergens to induce the release of
HMGB1 in KCs and its role in IL-18 production.
The inflammasome, induces the activation of caspase-1, an
enzyme that is central to the development of skin sensitization
(Ainscough et al., 2013). Using the caspase inhibitor Z-VAD-
FMK, we could demonstrate the involvement of the
inflammasome in allergen-induced IL-18 production in KCs.
It has been demonstrated that a multitude of diverse stimuli
can activate NLRP3, including adenosine triphosphate, silica,
asbestos, uric acid, and several bacterial products (Pedra et al.,
2009). Among the processes associated with toxin- and
crystal-mediated NLPR3 activation is the production of ROS
(Dostert et al., 2008). Evidence indicates that allergic and
inflammatory skin diseases are mediated by oxidative stress
(Okayama, 2005; Byamba et al., 2007). The disturbance of the
antioxidant systems, both enzymatic and nonenzymatic, can
lead to increased ROS, which can damage cellular
macromolecules (Byamba et al., 2007). Many in vitro
studies have revealed that ROS production is induced by
contact allergens (Corsini et al., 2013). The majority of
chemical allergens bind to the thiol group of cysteine
(Divkovic et al., 2005), which may lead to glutathione
depletion and oxidative stress, tissue damage, and increased
inflammation. We have previously demonstrated that PPD-
induced IL-18 production in KCs can be abrogated by the
antioxidant and NF-kB inhibitor pyrrolidine dithio-
carbamate (Galbiati et al., 2011), supporting the important
role of ROS in KC activation. It is proposed that mitochondria
may have a central role in NLRP3 activation (Zhou et al.,
2010), as these organelles are believed to be the main source
of cellular ROS (Tait and Green, 2012). Engagement of certain
TLRs (TLR 1, 2, and 4) leads to mitochondrial translocation of
the signaling adaptor TRAF6. At the mitochondria, TRAF6
interacts with ECSIT, a protein implicated in the assembly of
complex I, leading to its ubiquitylation, which results in
increased ROS production. Finally, among the protein
carbonylated by contact allergens, mitochondrial adenosine
triphosphate synthase was identified (Je et al., 2008), further
supporting the central role of mitochondria in the
pathophysiology of contact allergy. Using selective inhibitors
of the main intracellular sources of ROS, namely mitochon-
dria, NAPDH oxidase, and xanthine oxidase, we could
demonstrate that all these three sources appear to be
involved in allergen-induced IL-18 production, with a
different contribution depending on the allergen.
Among the several assays available to measure the levels of
ROS, we used the dichlorofluorescein diacetate assay. This
Figure 2. Effects of different sources of reactive oxygen species (ROS). NCTC2544 cells were treated with increasing concentrations of H2O2 or with
p-phenylenediamine (PPD) (30mg ml 1) as positive control. After incubation for 24 hours, cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay, whereas IL-18 (a), IL-1a (b), and IL-8 (c) were assessed by ELISAs. Results are expressed as mean±SD, n¼3. Statistical
analysis was performed with analysis of variance, followed by Bonferroni post-tests, with *Po0.05 and **Po0.01 versus vehicle-treated cells. In panel d, cells
were treated with PPD 30mg ml 1 in pink, 2,4-dinitrochlorobenzene (DNCB) 2mg ml1 in green, and citral 20mg ml 1 in orange for 5 minutes. The purple
histogram represents control cells.
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Figure 3. Role of the inflammasome and Toll-like receptor 4 (TLR4) in
allergen-induced IL-18 production. NCTC2544 cells were treated with
Z-VAD-FMK (10mM, (a) in purple) and anti-TLR4 (2mg ml1, (b) in green)
for 1 hour and then with p-phenylenediamine (PPD) (30mg ml1), 2,4-
dinitrochlorobenzene (DNCB) (2mg ml 1), citral (30mg ml1), or DMSO
(0.2% final concentration) as vehicle control for 24 hours. Results are expressed
as mean±SD, n¼4. Statistical analysis was performed with analysis of
variance followed by Bonferroni post-tests, with *Po0.05 and **Po0.01
versus vehicle-treated cells; #Po0.05 and ##Po0.01 versus cells treated with
inhibitors alone.
V Galbiati et al.
Role of ROS and HMGB1
www.jidonline.org 2723
assay is sensitive to oxidation by peroxynitrite and hydrogen
peroxide, whereas it is not suitable to measure nitric oxide,
hypochlorite, or superoxide in biological systems as it does
not distinguish between the different types of ROS (Byamba
et al., 2007). Furthermore, during our experiments, we had
noticed some ‘‘interference problem’’ with the pro-hapten
PPD. PPD is a white solid that becomes dark owing to air
oxidation, and we suppose that this color change could
interfere with the flow cytometry laser. As explained in the
Results section, KCs react differently to internal or to external
oxidative stimuli. Taken together, these evidence suggest that
external sources of ROS (i.e., H2O2), not induced by contact
allergens, are not able to modulate the IL-18 and IL-1a
response, hence indicating that this response is specific to
contact allergens.
In addition to the NLR, other pathogen-associated molecu-
lar pattern/DAMP receptors exist, including TLRs, c-type lectin
receptors, prostanoid receptors, and neuropeptide receptors
(Trinchieri and Sher, 2007), many of which have been
implicated in the development of skin sensitization. On
blocking TLR4 with a specific antibody, a significant
reduction in IL-18 production was observed, demonstrating
that allergen-induced IL-18 production is dependent upon
TLR4 activation.
Among the DAMPs that are able to activate TLR4, we
demonstrated the involvement of HMGB1 in allergen-induced
IL-18 production. He et al. (2012) speculated that HMGB1
could increase the synthesis of pro-IL-1b and pro-IL-18 in
THP-1 cells. We used glycirrizic acid, as it has been
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Figure 4. Role of high-mobility group protein B1 (HMGB1) in allergen-induced IL-18. (a) NCTC2544 cells were treated for 24 hours with p-phenylenediamine
(PPD) (30mg ml1), 2,4-dinitrochlorobenzene (DNCB) (2mg ml1), citral (30mg ml1), or DMSO. (b) Cells were treated with Z-VAD-FMK 10mM, and then
selected allergens were added for 24 hours. (c) Cells were treated for 1 hour with glycirrizic acid (100mM) and then contact allergens were added for 24 hours.
(d) HMGB1 release in EST1000 model. After topical exposure to chemicals, HMGB1 release was assessed by ELISA. Results are expressed as mean±SD,
n¼ 4. Statistical analysis was performed with two-way analysis of variance followed by Bonferroni post-tests, with *Po0.05 and **Po0.01 versus vehicle-treated
cells and ##Po0.01 versus cells treated with inhibitors alone.
Table 2. Effects of p-phenylenediamine on intracellular
IL-1 a and IL-8 production
Intracellular IL-1 a1 IL-82
Treatment Vehicle
Glycirrizic
acid Vehicle
Glycirrizic
acid n
Control 979±66 986±134 849±34 723±40 3
p-Phenylenediamine
30 mg ml 1
2,036±138 1,624±254 809±54 789±85 3
Cells were treated for 24 hours with p-phenylenediamine 30mg ml 1.
Cytokines were assessed by ELISA. Each value represents the mean±SD,
n¼3.
1Expressed as pg per mg.
2Expressed as pg per ml.
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demonstrated to be a direct inhibitor of HMGB1 (Girard,
2007; Mollica et al., 2007). Our data indicated that glycirrizic
acid significantly reduces allergen-induced IL-18 and IL-1a
production, supporting the involvement of HMGB1 in the
induction of these two cytokines. Otherwise, glycirrizic acid
does not affect the IL-8 levels, suggesting that HMGB1 is not
involved in the release of this cytokine following allergenic
stimulation.
Oxidative stress, the inflammasome, and TLR4 activation
are strictly cross-linked and they have a key role in the innate
immune and stress responses. TLR4, after a danger signal, can
activate NF-kB and MAPK pathways, inducing the release of
inflammatory cytokines such as IL-1b and IL-18. In addition,
TLR4 has the ability to further induce ROS, which have a triple
role: (1) they are able to directly stimulate inflammatory and
cytotoxic responses; (2) they can activate the NF-kB and
MAPK pathways; and (3) they can interact with the inflamma-
some leading to IL-1b and IL-18 release.
On the basis of our results, the following scenario can be
imagined: chemical sensitizers can induce oxidative stress
owing to their electrophilicity, which in turn activates the
inflammasome and HMGB1 release (and possibly other
DAMPs), which can activate TLR4. Activation of TLR4 will
result in NF-kB and p38 MAPK activation and in the
neosynthesis of IL-18.
More importantly, a similar scenario has been demonstrated
in vivo. In a mouse model of contact hypersensitivity the
ability of contact allergens to induced DAMPs and stimulation
of TLR4, trigger the production of proinflammatory cytokines,
which in turn promote the acquisition of skin sensitization,
and subsequently the elicitation of allergic contact dermatitis
(Martin et al., 2011).
In conclusion, we demonstrated a role of oxidative stress,
inflammasome activation, HMGB1 release, and TLR4 activa-
tion in contact allergen–induced IL-18 production in human
KCs.
MATERIALS AND METHODS
Chemicals
PPD, DNCB, and citral were chosen as relevant and representative of
the ‘‘universe’’ of contact allergens. All reagents were purchased at
the highest purity available. PPD, DNCB, citral, anti-TLR4 antibody,
allopurinol, rotenone, and glycirrizic acid were from Sigma Aldrich
(St Louis, MO), whereas Z-VAD-FMK (benzyloxycarbonyl-Val-Ala-
Asp (OMe)-fluoromethylketone) and diphenylene iodonium were
obtained from Tocris (St Louis, MO). Cell culture media and all
supplements were from Sigma Aldrich. All chemicals were dissolved
in DMSO (the final concentration of DMSO in culture medium was
0.2%).
Cell viability
The MTT assay measures mainly mitochondrial activity, which is
representative of cell viability, by quantifying dehydrogenase activity
(Gerlier and Thomasset, 1986). For the NCTC2544 cell line, 100ml of
cells (1.5–2.5 105 ml 1) were seeded in a 96-well plate and treated
with the selected inhibitors or DMSO as vehicle control (0.2% final
concentration). After an incubation period of 24 hours, the MTT assay
was performed.
For EST1000, after a 24-hour exposure, filter paper discs
impregnated with chemicals were removed from epidermal
equivalent inserts (EEs) or the epidermal surface, and the MTT analysis
was performed.
The absorbance of the resulting solutions was read at 595 nm in a
microplate reader (Molecular Devices, Sunnyvale, CA). Results are
expressed as the percentage of control cells.
Cell culture
For experiments using NCTC2544 cell line (Istituto Zooprofilattico di
Brescia, Brescia, Italy), cells were cultured in 24-well plates (0.5 ml
per well) at a density of 2.5 105 cell ml 1. Cells were treated in
RPMI 1640 containing 2 mM L-glutamine, 0.1 mg ml 1 streptomycin,
100 IU ml 1 penicillin, and 0.1% gentamycin, supplemented with
10% heated-inactivated fetal calf serum (media), and cultured at 371C
in 5% CO2.
NCTC2544 cells were treated with several inhibitors, namely
Z-VAD-FMK (10mM), anti-TLR4 antibody (1mg per well), glycirrizic
acid (100mM), diphenylene iodonium (0.5mM), rotenone (20mM), and
allopurinol (10mM) for different durations (30 minutes for anti-TLR4
antibody and 1 hour for all the other inhibitors), and then PPD
(30mg ml 1), DNCB (2mg ml 1), and citral (30mg ml 1) or DMSO as
vehicle control were added for 24 hours.
3D epidermal model EST1000
EST1000 (Epidermal Skin Test-1000–CellSystems, Biotechnology
GmbH, Troisdorf, Germany) was used in this study. EEs were
maintained according to the suppliers’ instructions at 37 1C, 5%
CO2, and 95% relative humidity. After 24 hours of equilibration time,
EEs were exposed to chemicals, as described in detail previously (dos
Santos et al., 2011; Teunis et al., 2013).
EEs were allowed to equilibrate for 24 hours at 37 1C, 5% CO2,
and then the chemicals were dissolved in either acetone:olive
oil (AOO 4:1) or 1% DMSO in culture medium. The vehicles
and chemicals were purchased from the same supplier:
acetone (cat. No. 20066.321) from VWR (Radnor, PA (VS)), and
olive oil (cat no. 01514) and DMSO (cat. no.154938) from Sigma
Aldrich.
For experiments, Finn Chamber filter paper discs 7.5 were
impregnated with chemicals or vehicle controls and applied topically
to the EE stratum corneum. Cultures were incubated with chemicals
for 24 hours; after chemical exposure, filter paper discs were removed
and metabolic activity was determined immediately by the MTT
assay, and culture supernatants were harvested and stored at  20 1C
for HMGB1 analysis by ELISA.
Cytokine production
For the assessment of IL-18 production after treatment, the monolayer
was gently washed twice with 0.5 ml of phosphate-buffered sali-
nePBS, and the cells were lysed in 0.25 ml of 0.5% Triton X-100 in
phosphate-buffered saline. The supernatants were collected for the
determination of HMGB1 release. Cell lysates and supernatants were
stored at  80 1C until measurement. Intracellular IL-18 content was
assessed by specific sandwich ELISA that was commercially available
(MBL, Nagoya, Japan). Results were normalized by cellular protein
content. The protein content of the cell lysate was measured using a
commercially available kit (Bicinchoninic acid solution and Copper
(II) sulfate solution-Sigma Aldrich). Stimulation index (SI) was
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calculated as follows:
SI ¼ IL 18 in chemical treated cells
IL 18 in vehicle or inhibitor treated cells
Differences in the absolute value of IL-18 were observed, also in
vehicle-treated cells. In control cells, historically, the intracellular IL-
18 content varied from 300 to 2,500 pg mg 1. As IL-18 levels are
highly dependent upon cell density, we speculated that this may be
due to the differences in the number of seeded cells, adhering to plate
well and survive, as well as to the differences in the IL-18 ELISA and
protein assessment performance, which may result in overestimation
or underestimation of IL-18 content. It is for this reason that the results
were normalized and expressed as stimulation index versus vehicle-
treated cells.
The HMGB1 release in the cell and epidermis supernatants was
assessed by specific sandwich ELISA that was commercially available
(IBL-international, Hamburg, Germany). Results are expressed as ng
per ml.
The IL-8 release and intracellular IL-1a content were assessed
by specific sandwich ELISAs that were commercially available
(BD Bioscience and Immunotools GmbH, Friesoythe, Germany,
respectively).
ROS
For the determination of intracellular ROS, the fluorescent intensity of
dichlorofluorescein diacetate (Molecular Probes, Eugene, OR)–oxi-
dized product DCF was measured. NCTC2544 cells were loaded for
30 minutes with DCFH (2mM) and kept away from light. After fixation,
cells were analyzed with FACScan Flow cytometry at time 0. After
this first acquisition, cells were treated with the three selected contact
allergens PPD (30mg ml 1), DNCB (2mg ml 1), citral (30mg ml 1),
or DMSO (0.2% final concentration) as vehicle control and acquired
at different time points: 5, 15, 30, and 60 minutes. The fluorescence
intensity of fluorophore DCF, which was formed by peroxide
oxidation of the nonfluorescent precursor, was measured (in the
FL1 channel set for log scale) using FACScan flow cytometry.
Data analysis
All experiments were repeated at least three times, with representative
results shown. Data are expressed as mean±SD. Statistical analysis
was performed using the InStat software version 3.0a (GraphPad
Software, La Jolla, CA). Statistical differences were determined using
analysis of variance followed by multiple comparison test, as
indicated in the legends. Effects were designated significant if
Po0.05.
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